• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磷酰胺氮芥对鸟苷和脱氧鸟苷的烷基化作用。

Alkylation of guanosine and deoxyguanosine by phosphoramide mustard.

作者信息

Mehta J R, Przybylski M, Ludlum D B

出版信息

Cancer Res. 1980 Nov;40(11):4183-6.

PMID:7471059
Abstract

Phosphoramide mustard, an active metabolite of cyclophosphamide, has been reacted separately with guanosine and deoxyguanosine in aqueous solution at pH 7.4. The major adduct which was formed in each case has been isolated by reverse-phase high-pressure liquid chromatography. The structure of the major adduct, as determined by a combination of ultraviolet and field desorption mass spectrometry, is that of phosphoramide mustard, one arm of which has reacted with guanosine or deoxyguanosine in position 7. These adducts are much less stable than was 7-methylguanosine, and they decompose with a half-life of 1.3 hr at 37 degrees and pH 7.4. This instability may contribute to the action of phosphoramide mustard at a molecular level.

摘要

磷酰胺氮芥是环磷酰胺的一种活性代谢产物,已在pH 7.4的水溶液中分别与鸟苷和脱氧鸟苷发生反应。每种情况下形成的主要加合物已通过反相高压液相色谱法分离出来。通过紫外和场解吸质谱联用确定的主要加合物的结构是磷酰胺氮芥的结构,其一条臂已与鸟苷或脱氧鸟苷的7位发生反应。这些加合物的稳定性远低于7-甲基鸟苷,在37℃和pH 7.4条件下,它们的半衰期为1.3小时,会发生分解。这种不稳定性可能在分子水平上有助于磷酰胺氮芥发挥作用。

相似文献

1
Alkylation of guanosine and deoxyguanosine by phosphoramide mustard.磷酰胺氮芥对鸟苷和脱氧鸟苷的烷基化作用。
Cancer Res. 1980 Nov;40(11):4183-6.
2
A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo.
Cancer Res. 1991 Feb 1;51(3):886-92.
3
Stabilities of 7-alkylguanosines and 7-deoxyguanosines formed by phosphoramide mustard and nitrogen mustard.
Chem Biol Interact. 1986 Jan;57(1):85-96. doi: 10.1016/0009-2797(86)90051-7.
4
Analysis and excision of ring-opened phosphoramide mustard-deoxyguanine adducts in DNA.DNA中环开磷酰胺氮芥-脱氧鸟嘌呤加合物的分析与切除
Cancer Res. 1982 Jul;42(7):2616-21.
5
Covalent sequestration of phosphoramide mustard by metallothionein--an in vitro study.
Drug Metab Dispos. 1999 Jul;27(7):786-91.
6
Alkylation of guanosine by phosphoramide mustard, chloromethine hydrochloride and chlorambucil.
Acta Pharmacol Toxicol (Copenh). 1984 Mar;54(3):214-20. doi: 10.1111/j.1600-0773.1984.tb01920.x.
7
Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.环磷酰胺代谢产物在大鼠肝微粒体系统及小鼠体内与DNA的结合
Cancer Res. 1985 Sep;45(9):4237-43.
8
Formation of a phosphoramide mustard-nucleotide adduct that is not by alkylation at the N7 position of guanine.
Biochem Biophys Res Commun. 1989 Sep 15;163(2):843-50. doi: 10.1016/0006-291x(89)92299-7.
9
Alkylation of N2 in deoxyguanosine by dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline.
Cancer Res. 1982 Jan;42(1):8-14.
10
1,3- vs 1,5-intramolecular alkylation reactions in isophosphoramide and phosphoramide mustards.
Chem Res Toxicol. 2004 Sep;17(9):1217-26. doi: 10.1021/tx030051k.

引用本文的文献

1
Genome Instability in Multiple Myeloma: Facts and Factors.多发性骨髓瘤中的基因组不稳定:事实与因素
Cancers (Basel). 2021 Nov 26;13(23):5949. doi: 10.3390/cancers13235949.
2
Characterization of nitrogen mustard formamidopyrimidine adduct formation of bis(2-chloroethyl)ethylamine with calf thymus DNA and a human mammary cancer cell line.双(2-氯乙基)乙胺与小牛胸腺DNA和人乳腺癌细胞系形成氮芥甲酰胺嘧啶加合物的表征
Chem Res Toxicol. 2015 Sep 21;28(9):1850-60. doi: 10.1021/acs.chemrestox.5b00297. Epub 2015 Sep 1.
3
Phosphoramide mustard exposure induces DNA adduct formation and the DNA damage repair response in rat ovarian granulosa cells.
磷酰胺芥暴露诱导大鼠卵巢颗粒细胞 DNA 加合物形成和 DNA 损伤修复反应。
Toxicol Appl Pharmacol. 2015 Feb 1;282(3):252-8. doi: 10.1016/j.taap.2014.11.017. Epub 2014 Dec 9.
4
Tandem mass spectrometry for characterization of covalent adducts of DNA with anticancer therapeutics.采用串联质谱法对与抗癌治疗药物发生共价结合的 DNA 进行特征分析。
Mass Spectrom Rev. 2013 Jul-Aug;32(4):247-66. doi: 10.1002/mas.21363. Epub 2012 Nov 13.
5
Using synthetic DNA interstrand crosslinks to elucidate repair pathways and identify new therapeutic targets for cancer chemotherapy.利用合成 DNA 链间交联物来阐明修复途径,并为癌症化疗确定新的治疗靶点。
Cell Mol Life Sci. 2010 Nov;67(21):3683-97. doi: 10.1007/s00018-010-0492-6. Epub 2010 Aug 21.
6
Mechanisms of drug combinations: interaction and network perspectives.药物组合的机制:相互作用与网络视角
Nat Rev Drug Discov. 2009 Feb;8(2):111-28. doi: 10.1038/nrd2683.
7
Specificity and kinetics of interstrand and intrastrand bifunctional alkylation by nitrogen mustards at a G-G-C sequence.氮芥在G-G-C序列处进行链间和链内双功能烷基化的特异性和动力学。
Nucleic Acids Res. 1997 Mar 15;25(6):1211-8. doi: 10.1093/nar/25.6.1211.
8
Cytotoxicity, DNA cross-linking, and DNA single-strand breaks induced by cyclophosphamide in a rat leukemia in vivo.环磷酰胺在大鼠白血病体内诱导的细胞毒性、DNA交联和DNA单链断裂。
Cancer Chemother Pharmacol. 1993;31(5):381-6. doi: 10.1007/BF00686152.
9
A 32P-postlabeling method for detecting unstable N-7-substituted deoxyguanosine adducts in DNA.一种用于检测DNA中不稳定的N-7-取代脱氧鸟苷加合物的32P后标记法。
Proc Natl Acad Sci U S A. 1994 Jul 19;91(15):7232-6. doi: 10.1073/pnas.91.15.7232.
10
Nucleic acid adducts of chemical carcinogens and mutagens.化学致癌物和诱变剂的核酸加合物
Arch Toxicol. 1983 Apr;52(4):249-85. doi: 10.1007/BF00316495.